# Trinity Biotech (TRIB) — Earnings

TRIB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/trib/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q4 2024 |
| Period end | Dec 31, 2024 |
| EPS actual | −$37.06 |
| EPS estimate | −$9.00 |
| EPS surprise | −311.83% |
| Revenue surprise | −3.90% |
| Revenue | $15.9M |
| Revenue estimate | $16.5M |
| Reported | May 15, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/888721/000117891325001821/zk2533204.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q4 2024 | May 15, 2025 | −$9.00 | −$37.06 | -311.83% | $16.5M | $15.9M |
| Q3 2024 | Nov 15, 2024 | −$16.20 | −$13.74 | 15.15% | $16.5M | $15.2M |
| Q2 2024 | Aug 20, 2024 | −$20.10 | −$21.42 | -6.55% | $15.0M | $15.8M |
| Q1 2024 | May 28, 2024 | −$18.00 | −$11.22 | 37.67% | $16.0M | $14.7M |
| Q4 2023 | Apr 5, 2024 | −$21.00 | −$21.53 | -2.54% | $15.0M | $13.4M |
| Q2 2023 | Oct 6, 2023 | −$13.50 | −$71.88 | -432.46% | $13.5M | $13.9M |
| Q1 2023 | Jul 10, 2023 | −$9.00 | −$24.78 | -175.39% | $18.5M | $14.8M |
| Q4 2022 | Mar 27, 2023 | −$9.00 | −$39.75 | -341.67% | $18.0M | $18.0M |
| Q3 2022 | Dec 16, 2022 | −$6.00 | −$35.21 | -486.76% | $19.5M | $19.5M |
| Q2 2022 | Nov 4, 2022 | −$4.50 | −$42.88 | -852.81% | $18.8M | $18.5M |
| Q1 2022 | Jul 1, 2022 | −$6.00 | −$11.73 | -95.42% | $20.0M | $18.8M |
| Q4 2021 | Apr 11, 2022 | $10.50 | $9.55 | -9.07% | $24.0M | $19.5M |
| Q3 2021 | Dec 16, 2021 | $12.00 | $7.33 | -38.92% | $24.3M | $22.0M |
| Q2 2021 | Sep 9, 2021 | $10.50 | $31.80 | 202.86% | $24.0M | $25.8M |
| Q1 2021 | May 27, 2021 | $9.00 | $15.15 | 68.33% | $24.0M | $25.6M |
| Q4 2020 | Mar 26, 2021 | $21.00 | $53.85 | 156.43% | $28.0M | $32.8M |
| Q3 2020 | Nov 17, 2020 | $15.00 | $52.50 | 250.00% | $28.0M | $32.0M |
| Q2 2020 | Aug 25, 2020 | $0.00 | −$5.40 | 0.00% | $13.0M | $16.0M |
| Q1 2020 | May 27, 2020 | $4.50 | $7.95 | 76.67% | $19.0M | $21.2M |

## Frequently Asked Questions

### When did Trinity Biotech (TRIB) last report earnings?

Trinity Biotech last reported on May 15, 2025, covering fiscal Q4 2024.

### Did TRIB beat earnings estimates?

No. Trinity Biotech reported EPS of −$37.06 for Q4 2024 against a −$9.00 estimate — a 311.83% miss.

### How much revenue did TRIB report last quarter?

Trinity Biotech reported $15.9M in revenue for Q4 2024, against a consensus estimate of $16.5M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).